Evidence map›Paper›PMID 37319239›Full record

ArticlePloS one2023

Demographic, social, and behavioral correlates of SARS-CoV-2 seropositivity in a representative, population-based study of Minnesota residents.

Jordan Abhold, Abigail Wozniak, John Mulcahy, Sara Walsh, Evelyn Zepeda, Ryan Demmer, Stephanie Yendell, Craig Hedberg, Angela Ulrich, Rebecca Wurtz and 1 more

Abstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. SARS-CoV-2 Seroprevalence Survey in Grocery Store Workers-Minnesota, 2020-2021.International journal of environmental research and public health · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jordan AbholdDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, United States of America.
Abigail WozniakOpportunity & Inclusive Growth Institute, Federal Reserve Bank of Minneapolis, Minneapolis, MN, United States of America.
John MulcahyDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, United States of America.
Sara WalshHealth Sciences, NORC at the University of Chicago, Chicago, IL, United States of America.
Evelyn ZepedaHealth Sciences, NORC at the University of Chicago, Chicago, IL, United States of America.ORCID 0000-0003-1450-7745
Ryan DemmerDivision of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, United States of America.
Stephanie YendellHealth Risk Intervention Unit, Minnesota Department of Health, St. Paul, MN, United States of America.
Craig HedbergDivision of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, MN, United States of America.
Angela UlrichDivision of Environmental Health Sciences, School of Public Health, University of Minnesota, Minneapolis, MN, United States of America.
Rebecca WurtzSchool of Public Health, University of Minnesota, Minneapolis, MN, United States of America.ORCID 0000-0002-0501-7317
Timothy BeebeSchool of Public Health, University of Minnesota, Minneapolis, MN, United States of America.ORCID 0000-0003-4700-2436

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMonitoring COVID-19 infection risk in the general population is a public health priority. Few studies have measured seropositivity using representative, probability samples. The present study measured seropositivity in a representative population of Minnesota residents prior to vaccines and assess the characteristics, behaviors, and beliefs of the population at the outset of the pandemic and their association with subsequent infection.

methodsParticipants in the Minnesota COVID-19 Antibody Study (MCAS) were recruited from residents of Minnesota who participated in the COVID-19 Household Impact Survey (CIS), a population-based survey that collected data on physical health, mental health, and economic security information between April 20 and June 8 of 2020. This was followed by collection of antibody test results between December 29, 2020 and February 26, 2021. Demographic, behavioral, and attitudinal exposures were assessed for association with the outcome of interest, SARS-CoV-2 seroprevalence, using univariate and multivariate logistic regression.

resultsOf the 907 potential participants from the CIS, 585 respondents then consented to participate in the antibody testing (64.4% consent rate). Of these, results from 537 test kits were included in the final analytic sample, and 51 participants (9.5%) were seropositive. The overall weighted seroprevalence was calculated to be 11.81% (95% CI, 7.30%-16.32%) at of the time of test collection. In adjusted multivariate logistic regression models, significant associations between seroprevalence and the following were observed; being from 23-64 and 65+ age groups were both associated with higher odds of COVID-19 seropositivity compared to the 18-22 age group (17.8 [1.2-260.1] and 24.7 [1.5-404.4] respectively). When compared to a less than $30k annual income reference group, all higher income groups had significantly lower odds of seropositivity. Reporting practicing a number of 10 (median reported value in sample) or more of 19 potential COVID-19 mitigation factors (e.g. handwashing and mask wearing) was associated with lower odds of seropositivity (0.4 [0.1-0.99]) Finally, the presence of at least one household member in the age range of 6 to 17 years old was associated with higher odds of seropositivity (8.3 [1.2-57.0]).

conclusionsThe adjusted odds ratio of SARS-CoV-2 seroprevalence was significantly positively associated with increasing age and having household member(s) in the 6-17 year age group, while increasing income levels and a mitigation score at or above the median were shown to be significantly protective factors.

Indexed as

COVID-19SARS-CoV-2AdolescentAntibodies, ViralChildDemographyHumansMinnesotaSeroepidemiologic StudiesAntibodies, Viral

Identifiers

PMID37319239
PMCPMC10270347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.